« Back to Record
Agostinetto, E., de Azambuja, E., & Lambertini, M. (2023). Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer, 9(1), 14. doi:10.1038/s41523-023-00515-4
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/372618



